Unit
- Clinical trial definition: A clinical trial is a research study conducted with human volunteers to evaluate the safety and efficacy of medical interventions, including drugs, devices, and biologics. These studies follow a structured protocol designed to answer specific research questions while protecting participant rights and well-being.
- Phase I trials: The first human studies, typically involving 20 to 80 healthy volunteers, focus on determining the safety profile, dosing range, and pharmacokinetics of an investigational product. These studies establish the maximum tolerated dose and identify common adverse effects.
- Phase II trials: Involving 100 to 300 participants with the target disease, these studies assess the efficacy of the intervention and further evaluate its safety. They help determine optimal dosing and provide preliminary evidence of therapeutic effect.
- Phase III trials: Large-scale studies with 1,000 to 3,000 participants confirm efficacy, monitor side effects, and compare the new intervention to standard treatments. Results from Phase III trials are typically required for regulatory approval.
- Phase IV trials: Post-marketing studies conducted after regulatory approval to gather additional information on long-term safety, effectiveness, and optimal use in broader patient populations over extended periods.
- Site operations role: Clinical trial sites are responsible for executing study protocols, enrolling participants, collecting data, and ensuring compliance with regulatory and ethical standards. Site operations include all administrative and clinical activities required to conduct a trial.
- Key site personnel: Principal Investigator (PI) leads the study at the site, supported by sub-investigators, study coordinators, data managers, and regulatory specialists. Each role has specific responsibilities defined by regulations and delegation logs.
- Lifecycle of a trial: A clinical trial progresses through preparation, start-up, active enrollment, treatment and follow-up, data lock, and close-out. Each phase requires coordinated efforts among site staff, sponsors, and regulatory bodies.
- Informed consent process: Site staff must obtain voluntary informed consent from each participant before any study specific procedures begin. The process involves explaining the study purpose, potential risks, benefits, alternatives, and participant rights in lay language. Staff must ensure comprehension, answer questions, and document the discussion on an IRB approved consent form.
- Source data verification: Clinical research associates from the sponsor or CRO conduct routine monitoring visits to verify data integrity. They compare entries in case report forms against original source documents such as medical records and lab reports. This process confirms that the data submitted is accurate, complete, and derived from verifiable sources.
- Essential document management: Sites maintain a Trial Master File or regulatory binder containing essential documents that demonstrate compliance. Key documents include the signed protocol and amendments, IRB approvals, delegation of authority logs, staff training records, and correspondence. Proper organization of these files is essential for inspection readiness and overall trial integrity.
- Safety reporting obligations: Identifying and reporting adverse events is a fundamental site responsibility. Personnel must assess each event for seriousness, severity, and causality. Serious adverse events require immediate notification to the sponsor and reviewing IRB within strict regulatory timeframes. Accurate and timely safety reporting protects participants and maintains regulatory compliance.
- Recruitment and retention strategies: Achieving enrollment goals requires a proactive recruitment plan tailored to the site population. Strategies may include screening electronic medical records, conducting community outreach, and collaborating with patient advocacy groups. Retention efforts focus on minimizing participant burden through flexible scheduling, travel reimbursements, and maintaining open communication throughout the trial.
Regulatory Note
Regulation: Clinical trials must be conducted in accordance with the Declaration of Helsinki, which outlines ethical principles for medical research involving human subjects. The International Council for Harmonisation (ICH) Good Clinical Practice (GCP) guidelines provide a unified standard for trial conduct.
ICH E6(R2) Good Clinical Practice, Section 2: The Principles of ICH GCP
Quick Revision
- Clinical trials are research studies evaluating medical interventions in human volunteers.
- Trials proceed through four phases: I (safety), II (efficacy), III (confirmatory), IV (post-market).
- Site operations encompass protocol execution, enrollment, data collection, and compliance.
- Key site roles include PI, sub-investigators, coordinators, and regulatory staff.